|
Sep 12
|
Icon PLC (ICLR) Surges 3.3%: Is This an Indication of Further Gains?
|
|
Sep 10
|
Viatris Announces Expiration and Results of Any and All Cash Tender Offers
|
|
Sep 10
|
Viatris Announces the Pricing Terms of Pending Any and All Cash Tender Offers
|
|
Sep 9
|
Viatris 2023 Sustainability Report: Breaking Down Systemic Barriers To Access Through Policy Engagement
|
|
Aug 6
|
Why Is Viatris Inc. (VTRS) the Best Dividend-Paying Stock to Buy Under $15?
|
|
Aug 6
|
Theravance (TBPH) Q2 Loss Wider Than Expected, Revenues Rise Y/Y
|
|
Aug 6
|
Viatris Announces Second Quarter 2024 Dividend
|
|
Aug 5
|
Novartis, Viatris face new lawsuit over 'HeLa' cell misuse claims
|
|
Aug 5
|
Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?
|
|
Aug 5
|
Seeking Clues to Viatris (VTRS) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
|
|
Aug 1
|
Earnings Preview: Viatris (VTRS) Q2 Earnings Expected to Decline
|
|
Jul 29
|
Viatris 2023 Sustainability Report: Empowering Healthcare Workers
|
|
Jul 26
|
3 Surprisingly Underrated Stocks to Buy Right Now
|
|
Jul 23
|
Viatris 2023 Sustainability Report: Building Access Through a Global and Flexible Supply Chain
|
|
Jun 26
|
Here's Why You May Invest in Theravance (TBPH) Stock Now
|
|
Jun 25
|
Viatris Named to TIME’s World’s Most Sustainable Companies 2024 List
|
|
Jun 14
|
Regeneron Pharmaceuticals Wins Injunctions Against Biosimilars to Eye Disease Drug Eylea
|
|
May 14
|
Theravance (TBPH) Q1 Earnings Top, Revenues Match Estimates
|
|
May 10
|
Viatris Inc. (NASDAQ:VTRS) Q1 2024 Earnings Call Transcript
|
|
May 10
|
Viatris Inc. (VTRS) Q1 2024 Earnings: Aligns with EPS Projections Amidst Strategic Shifts and ...
|